The COVID-19 crisis has exposed our fragility, with health systems strained and social safety nets stretched to the limit. The economic downturn caused by the global pandemic may drive more people to substance abuse or leave them vulnerable to involvement in drug trafficking and related crime. According to the World Drug Report, 2020 published by UN Office on Drugs and Crime (UNODC) recently, about 269 million people used drugs in 2018, which was 30% more than the 2009 figure, with adolescents and young adults accounting for the largest share of users and also, it has highlighted the possible consequences of COVID-19 on the production, supply and consumption of illicit drugs. An Annual Action Plan for 2020-21 called Nasha Mukt Bharat was e-launched for the 272 Most Affected Districts by Minister of State for Social Justice and Empowerment on the occasion of “International Day Against Drug Abuse and Illicit Trafficking”.
In March, India, like several countries shut down liquor shops. During this period, the mental health of many alcoholics deteriorated with several even attempting suicides. When the shops were reopened in May, long queues and chaotic crowds with blatant disregard for social distancing norms were observed across the country. States have started online sale of liquor. This calls for a look into the issue of alcoholism in India.
Recently, a private hospital in Delhi became the first hospital in India to use convalescent plasma therapy to treat two …
The New Drugs and Clinical Trial Rules, 2019 released by the government seeks to enable faster approvals and to cut down on red tape with respect to the clinical trials in India. It seeks to promote clinical research in India by providing for a predictable, transparent and effective regulation for clinical trials and by guaranteeing faster accessibility of new drugs to the Indian population. Thus it has the potential to reinvigorate the clinical research industry, which was almost on its death bed a few years ago.
This article answers the following questions in an analytical manner.
- What are clinical trials?
- What is the need for clinical trials?
- How Clinical trials are conducted?
- Why is India a popular destination for Clinical trials?
- What is the regulatory mechanism for Clinical Trials in India?
- What are the key Issues regarding Clinical Trials in India?
- What are the measures taken by the government to solve those issues?
- What are the features and significances of the new rules of 2019?
- What are the suggestions to further improve the scenario?
The Ministry of Chemicals & Fertilizers has recently released the Drugs (Prices Control) Amendment Order, 2019 which prescribes that the drugmaker who has brought in an innovative patented drug will be exempt from the price control rules for 5 years from the date of marketing. It is meant to strike the right balance between consumer and producer interests. However, it falls short of addressing certain concerns regarding the drug pricing regulation in India.
The Drug Technical Advisory Board (DTAB) in July 2018 has recommended banning 343 “irrational” fixed-dose combination (FDC) drugs.
Oxytocin is also known as the love hormone, is released naturally in human bonding activities
such as childbirth, breastfeeding, and sex. Oxytocin is made in the hypothalamus region of the brain